Dr. Trever Bivona | CureTalks
Dr. Trever Bivona is a laboratory-based physician scientist at the University of California, San Francisco. He is a medical oncologist and Professor of Medicine and of Cellular and Molecular Pharmacology who leads a research program focused on signal transduction and cancer genetics and the molecular basis of tumor initiation, progression, and drug resistance. A major area of interest is the function and therapeutic targeting of oncogenic receptor tyrosine kinases and RAS. The goal of this research program is to understand the regulatory principles underlying cancer cell signaling and tumor evolution to improve cancer therapy and patient survival. Dr. Bivona received a NIH Director’s New Innovator Award and is an elected member of the American Society for Clinical Investigation. He is currently Principal Investigator of the NIH/NCI U54 Bay Area Drug Resistance and Sensitivity Center.
Lung cancer, the most common cancer type with the highest mortality, can largely be categorized by the genetic mutations that cause it. By…